PcG complexes and chromatin silencing

doi:10.1016/S0959-437X(97)80135-9

Current Opinion in Genetics & Development

Volume 7, Issue 2, April 1997, Pages 249-258

https://doi.org/10.1016/S0959-437X(97)80135-9 Get rights and content

Abstract

Silencing complexes in yeast and in the fly have many similarities. This repressive complex is assembled by a chain of recruitment; its extent and stability depend on the concentration of components and affect an extended chromatin region, probably through interactions with nucleosomes. Recent results show that assembly of the complex is antagonized by transcriptional activity in the region but is favored by interactions with other complexes nearby or in other regions that associate in the same nuclear environment. How such a complex interferes with transcriptional activity is not entirely clear but current evidence suggests that they compete with the chromatin structure required for the binding of activators.

References (69)

H Renauld et al.
Silent domains are assembled continuously from the telomere and are defined by promoter distance and strength, and by SIR3 dosage
Genes Dev
(1993)
J Müller et al.
Function of the Polycomb protein is conserved in mice and flies
Development
(1995)
BP Brunk et al.
Drosophila genes Posterior Sex Combs and Suppressor two of zeste encode proteins with homology to the murine BMI-1 oncogene
Nature
(1991)
Van Lohuizen M et al.
Sequence similarity between the mammalian bmi-1 proto-oncogene and the Drosophila regulatory genes Psc and Su(z)2
Nature
(1991)
L Rastelli et al.
Related chromosome binding sites for zeste, suppressors of zeste and Polycomb group proteins in Drosophila and their dependence on Enhancer of zeste function
EMBO J
(1993)
EC Martin et al.
The Polycomb group gene Posterior Sex Combs encodes a chromosomal protein
Development
(1993)
A Lonie et al.
Molecular characterisation of the Polycomblike gene of Drosophila melanogaster, a trans-acting negative regulator of homeotic gene expression
Development
(1994)
G Farkas et al.
The Trithorax-like gene encodes the Drosophila GAGA factor
Nature
(1994)
BM Herschbach et al.
Transcriptional repression directed by the yeast α2 protein in vitro
Nature
(1994)
BM Turner et al.
Histone H4 isoforms acetylated at specific lysine residues define individual chromosomes and chromatin domains in Drosophila polytene nuclei
Cell
(1992)

S Marcand et al.

Silencing of genes at nontelomeric sites in yeast is controlled by sequestration of silencing factors at telomeres by Rap1 protein

Genes Dev

(1996)

A Hecht et al.

Spreading of transcriptional repressor SIR3 from telomeric heterochromatin

Nature

(1996)

SW Buck et al.

Action of a RAP1 carboxy-terminal silencing domain reveals an underlying competition between HMR and telomeres in yeast

Genes Dev

(1995)

A Hecht et al.

Histone H3 and H4 N-termini interact with SIR3 and SIR4 proteins: a molecular model for the formation of heterochromatin in yeast

Cell

(1995)

L Maillet et al.

Evidence for silencing compartments within the yeast nucleus: a role for telomere proximity and Sir protein concentration in silencer-mediated repression

Genes Dev

(1996)

T Triolo et al.

Role of interactions between the origin recognition complex and SIR1 in transcriptional silencing

Nature

(1996)

C Boscheron et al.

Cooperation at a distance between silencers and proto-silencers at the yeast HML locus

EMBO J

(1996)

SCR Elgin

Heterochromatin and gene regulation in Drosophila

Curr Opin Genet Dev

(1996)

J Simon

Locking in stable states of gene expression: transcriptional control during Drosophila development

Curr Opin Cell Biol

(1995)

V Pirrotta

Chromatin complexes regulating gene expression in Drosophila

Curr Opin Genet Dev

(1995)

JS Platero et al.

Functional analysis of the chromodomain of HP1

EMBO J

(1995)

M Kanno et al.

mel-18, a Polycomb group-related mammalian gene, encodes a transcriptional negative regulator with tumor suppressive activity

EMBO J

(1995)

NMT Van der Lugt et al.

Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene

Gene Dev

(1994)

T Akasaka et al.

A role for mel-18, a Polycomb group-related vertebrate gene, in the anteroposterior specification of the axial skeleton

Development

(1996)

D Bornemann et al.

The Drosophila Polycomb group gene Sex comb on midleg (Scm) encodes a zinc finger protein with similarity to polyhomeotic protein

Development

(1996)

B Tschiersch et al.

The protein encoded by the Drosophila position-effect variegation suppressor gene Su(var)3–9 combines domains of antagonistic regulators of homeotic gene complexes

EMBO J

(1994)

T Gutjahr et al.

The Polycomb-group gene, extra sex combs, encodes a nuclear member of the WD-40 repeat family

EMBO J

(1995)

J Simon et al.

The extra sex combs product contains WD40 repeats and its time of action implies a role distinct from other Polycomb group products

Mech Dev

(1995)

SS Sathe et al.

The extra sex combs protein contains WD motifs essential for its function as a repressor of the homeotic genes

Mech Dev

(1995)

EJ Neer et al.

G protein heterodimers: new structures propel new questions

Cell

(1996)

K Komachi et al.

The WD repeats of Tup1 interact with the homeodomain protein a2

Genes Dev

(1994)

A Schumacher et al.

Positional cloning of a global regulator of anterior—posterior patterning in mice

Nature

(1996)

K Ekwall et al.

The chromodomain protein Swi6: a key component at fission yeast centromeres

Science

(1955)

A Franke et al.

Polycomb and polyhomeotic are constituents of a multimeric protein complex in chromatin of Drosophilia melanogaster

EMBO J

(1992)

Cited by (208)

Acquisition of neural fate by combination of BMP blockade and chromatin modification
2023, iScience
Neural induction is a process where naive cells are converted into committed cells with neural characteristics, and it occurs at the earliest step during embryogenesis. Although the signaling molecules and chromatin remodeling for neural induction have been identified, the mutual relationships between these molecules are yet to be fully understood.
By taking advantage of the neural differentiation system of mouse embryonic stem (ES) cells, we discovered that the BMP signal regulates the expression of several polycomb repressor complex (PRC) component genes. We particularly focused on Polyhomeotic Homolog 1 (Phc1) and established Phc1-knockout (Phc1-KO) ES cells. We found that Phc1-KO failed to acquire the neural fate, and the cells remained in pluripotent or primitive non-neural states. Chromatin accessibility analysis suggests that Phc1 is essential for chromatin packing. Aberrant upregulation of the BMP signal was confirmed in the Phc1 homozygotic mutant embryos. Taken together, Phc1 is required for neural differentiation through epigenetic modification.
ASXL1 mutation in clonal hematopoiesis
2020, Experimental Hematology
Recent advances in DNA sequencing technologies have enhanced our knowledge about several diseases. Coupled with easy accessibility to blood samples, hematology plays a leading role in understanding the process of carcinogenesis. Clonal hematopoiesis (CH) with somatic mutations is observed in at least 10% of people over 65 years of age, without apparent hematologic disorders. CH is associated with increased risk of hematologic malignancies, which is indicative of a pre-malignant condition. Therefore, a better understanding of CH will help elucidate the mechanism of multi-step tumorigenesis in the hematopoietic system. Somatic mutations of ASXL1 are frequently detected in CH and myeloid malignancies. Although ASXL1 does not have any catalytic activity, it is involved in multiple histone modifications including H3K4me3, H3K27me3, and H2AK119Ub, suggesting its function as a scaffolding protein. Most ASXL1 mutations detected in CH and myeloid malignancies are frameshift or nonsense mutations of the last exon, generating a C-terminally truncated protein. Deletion of Asxl1 or expression of mutant ASXL1 in mice alters histone modifications and facilitates aberrant gene expression, resulting in myeloid transformation. On the contrary, these mice exhibit impaired functioning of hematopoietic stem cells (HSCs), suggesting the negative effects of ASXL1 mutations on stem cell function. Thus, how ASXL1 mutations induce a clonal advantage of hematopoietic cells and subsequent CH development has not been elucidated. Here, we have reviewed the current literature that enhances our understanding of ASXL1, including its mutational landscape, function, and involvement of its mutation in pathogenesis of CH and myeloid malignancies. Finally, we discuss the potential causes of CH harboring ASXL1 mutations with our latest knowledge.
Alterations in epigenetic regulation contribute to neurodegeneration of ataxia-telangiectasia
2019, Chromatin Signaling and Neurological Disorders
The concept of involvement of epigenetic dysregulation in the neurodegeneration of Ataxia-telangiectasia (A-T) patients has strongly gained ground in recent years. Abnormal changes in multiple epigenetic regulations essentially necessitate that A-T mutated (ATM) deficiency leads to nuclear accumulation of histone deacetylase 4, elevated H3K27me3, and deregulated active DNA demethylation. Alternately, such alterations in distinct epigenetic systems may also be reacquired through cell cycle reentry and abnormal DNA-damage response (DDR) in ATM deficiency. In particular, loss of 5-hydroxymethylcytosine (5-hmC) plays a key role in Purkinje cell vulnerability in A-T brain. Meanwhile, ten-eleven translocation dioxygenase (TET1)- and TET3-mediated DNA demethylation directly regulate ATM- and ataxia telangiectasia and Rad3-related protein (ATR)-dependent DDR. In this chapter, the recent advances in elucidating epigenetic bases that regulate the A-T neurodegeneration and ATM/ATR-dependent DNA-damage signaling will be presented.
Polycomb Responds to Low Levels of Transcription
2017, Cell Reports
How is Polycomb (Pc), a eukaryotic negative regulator of transcription, targeted to specific mammalian genes? Our genome-wide analysis of the Pc mark H3K27me3 in murine cells revealed that Pc is preferentially associated with CpG island promoters of genes that are transcribed at a low level and less so with promoters of genes that are either silent or more highly expressed. Studies of the CpG island promoter of the Kit gene demonstrate that Pc is largely absent when the gene is silent in myeloid cells, as well as when the gene is highly expressed in mast cells. Manipulations that increase transcription in the former case, and reduce it in the latter, increase Pc occupancy. The average negative effect of Pc, we infer, is about 2-fold. We suggest possible biological roles for such negative effects and propose a mechanism by which Pc might be recruited to weakly transcribed genes.
Nucleotide substitutions revealing specific functions of Polycomb group genes
2015, Molecular Genetics and Metabolism
Citation Excerpt :
SFMBT also contains the conserved protein-interacting SAM domain [30,31]. It has been shown that the SAM domains are able to self-associate, bind to other SAM domains and form heterotypic interactions with other, non-SAM domain-containing proteins [32,33]. Importantly, SAM domains have been shown to form a helical polymer structure, which provides a possible mechanism for the extension of PcG complexes [34].
POLYCOMB group (PCG) proteins belong to the family of epigenetic regulators of genes playing important roles in differentiation and development. Mutants of PcG genes were isolated first in the fruit fly, Drosophila melanogaster, resulting in spectacular segmental transformations due to the ectopic expression of homeotic genes. Homologs of Drosophila PcG genes were also identified in plants and in vertebrates and subsequent experiments revealed the general role of PCG proteins in the maintenance of the repressed state of chromatin through cell divisions. The past decades of gene targeting experiments have allowed us to make significant strides towards understanding how the network of PCG proteins influences multiple aspects of cellular fate determination during development. Being involved in the transmission of specific expression profiles of different cell lineages, PCG proteins were found to control wide spectra of unrelated epigenetic processes in vertebrates, such as stem cell plasticity and renewal, genomic imprinting and inactivation of X-chromosome. PCG proteins also affect regulation of metabolic genes being important for switching programs between pluripotency and differentiation. Insight into the precise roles of PCG proteins in normal physiological processes has emerged from studies employing cell culture-based systems and genetically modified animals. Here we summarize the findings obtained from PcG mutant fruit flies and mice generated to date with a focus on PRC1 and PRC2 members altered by nucleotide substitutions resulting in specific alleles. We also include a compilation of lessons learned from these models about the in vivo functions of this complex protein family. With multiple knockout lines, sophisticated approaches to study the consequences of peculiar missense point mutations, and insights from complementary gain-of-function systems in hand, we are now in a unique position to significantly advance our understanding of the molecular basis of in vivo functions of PcG proteins.
Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer
2013, Mitochondrion
Thioredoxin binding protein (TXNIP) has multiple functions and plays an important role in redox homeostasis. TXNIP increases the production of reactive oxygen species (ROS), and oxidative stress, resulting in cellular apoptosis. It has been identified as a tumor suppressor gene (TSG) in various solid tumors and hematological malignancies. In the present review, we will first provide an overview of TXNIP protein and function, followed by a summary of the major studies that have demonstrated the frequent repression of TXNIP in cancers. Functional characterization of TXNIP knockout mouse model is summarized. We will then discuss the use of small molecular inhibitors to reactivate TXNIP expression as a novel anticancer strategy.

View all citing articles on Scopus

View full text